Every earnings call for SAKAR — management tone, guidance, KPIs and promise tracking, quarter by quarter.
SAKAR · 3 transcripts · Healthcare · latest Q4 FY26Sakar Healthcare Limited has 3 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue (Q4 FY26) ₹71 cr (+42% YoY); EBITDA (Q4 FY26) ₹26 cr (+67% YoY); EBITDA Margin (Q4 FY26) 37.0%. Q4 FY26 Revenue from operations grew 42% YoY to ₹71.097 crores.
Read full transcript & analysisRevenue from Operations 7034 lakhs (+62% YoY); EBITDA 1859 lakhs (+58% YoY); EBITDA Margin 26%. Q3 FY26 Revenue from operations grew 62% YoY to INR 7,034 lakhs.
Read full transcript & analysisRevenue (Q2 FY26) ₹58 cr (+35% YoY); EBITDA (Q2 FY26) ₹11 cr (−1% YoY); EBITDA Margin (Q2 FY26) 20.0%. H1 FY26 revenue grew 31.4% YoY to ₹110.30 crores.
Read full transcript & analysis